Raamdeo Agrawal, the boss man of Motilal Oswal, recommended a stock on the basis...
Granules India
Emkay has claimed that a mid-cap Pharma stock, which is already certified as a...
Eminent technical analysis experts have expressed the unanimous opinion that a small-cap Pharma stock,...
Pharma stocks have lost favour amongst investors owing to the USFDA regulatory headwinds. However,...
Amar Ambani of IIFL has evaluated the Q4FY16 performance of several stocks and given...
A mid-cap Pharma stock projected as a potential 100-bagger by the wizards at Motilal...
Motilal Oswal, the founder of MOFSL, has recommended five large-cap stocks and five small-cap...
Nearly a year has passed since Motilal Oswal’s recomm endation of seven potential 100-Bagger...
Three whiz-kid investors have not only revealed top secrets on how to find to...
Amar Ambani of IIFL has evaluated the Q2FY16 performance of several stocks and given...
